|
|
||||||||
-adrenergic-induced acceleration of cardiac
relaxation
1 Department of Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153; and 2 Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267
| |
ABSTRACT |
|---|
|
|
|---|
Activation of
cAMP-dependent protein kinase A (PKA) in ventricular myocytes by
isoproterenol (Iso) causes phosphorylation of both phospholamban
(PLB) and troponin I (TnI) and accelerates relaxation by up to twofold.
Because PLB phosphorylation increases sarcoplasmic reticulum (SR) Ca
pumping and TnI phosphorylation increases the rate of Ca dissociation
from the myofilaments, both factors could contribute to the
acceleration of relaxation seen with PKA activation. To compare
quantitatively the role of TnI versus PLB phosphorylation, we measured
relaxation rates before and after maximal Iso treatment for twitches of
matched amplitudes in ventricular myocytes and muscle from wild-type
(WT) mice and from mice in which the PLB gene was knocked out (PLB-KO).
Because Iso increases contractions, even in the PLB-KO mouse,
extracellular [Ca] or sarcomere length was adjusted to
obtain matching twitch amplitudes (in the presence and absence of Iso).
In PLB-KO myocytes and muscles (which were allowed to shorten), Iso did
not alter the time constant (
) of relaxation (~29 ms). However,
with increasing isometric force development in the PLB-KO muscles, Iso
progressively but modestly accelerated relaxation (by 17%). These
results contrast with WT myocytes and muscles where Iso greatly reduced
of cell relaxation and intracellular Ca concentration decline (by
30-50%), independent of mechanical load. The Iso treatment used
produced comparable increases in phosphorylation of TnI and PLB in WT. We conclude that the effect of
-adrenergic activation on relaxation is mediated entirely by PLB phosphorylation in the absence of external
load. However, TnI phosphorylation could contribute up to 14-18%
of this lusitropic effect in the WT mouse during maximal isometric contractions.
protein kinase A; relaxation; isoproterenol; calcium concentration
| |
INTRODUCTION |
|---|
|
|
|---|
ACTIVATION of the sympathetic nervous system leads to
the secretion of catecholamines, which stimulate
-adrenergic
receptors in the heart. Cardiac
-adrenergic stimulation activates
membrane-bound adenylyl cyclase and leads to the formation of cAMP and
activation of protein kinase A (PKA). There are several intracellular
proteins that can be phosphorylated by PKA, but the dominant ones
quantitatively are phospholamban (PLB) (20, 32, 34) and troponin I
(TnI) (19, 33). PLB is a key regulator of the sarcoplasmic reticulum (SR) Ca-ATPase in cardiac cells. Dephosphorylated PLB is closely associated with the SR Ca-ATPase and acts as an inhibitor of the SR Ca
pump (13, 15, 30, 31). On phosphorylation by PKA, the inhibitory effect
is relieved (20, 34). This allows greater Ca transport at a given
intracellular Ca concentration ([Ca]i), and
hence, the heart relaxes faster (lusitropic effect). Phosphorylation of
TnI, which interacts with troponin C (TnC), decreases the affinity of
TnC for Ca (33). This reduction in Ca affinity is mediated by an
increase in the off rate of Ca from the myofilaments and could thereby
accelerate cardiac relaxation (28).
Because both PLB and TnI are phosphorylated during
-adrenergic
stimulation of the myocytes, it is difficult to isolate the individual
roles of PLB and TnI on the lusitropic effect of
-adrenergic activation in the heart. Indirect studies in ventricular muscle have
suggested that the acceleration of relaxation with isoproterenol (Iso)
could be attributed mainly to the SR Ca-pump stimulation rather than
decreased myofilament Ca sensitivity (9, 26). Indeed, after withdrawal
of
-adrenergic activation in the intact heart, inotropic and
lusitropic states recover with a time course that more closely matches
that of the dephosphorylation of PLB than of TnI (35). Recent studies
in skinned cardiac muscle fibers using photolysis of caged Ca chelator
diazo-2 have been equivocal (14, 38). Whereas Zhang et al. (38)
concluded that cardiac TnI phosphorylation increases the rate of muscle
relaxation, Johns et al. (14) concluded that TnI phosphorylation was
not involved in the cardiac lusitropic effect.
Luo et al. (23) ablated the PLB gene in the mouse and found that basal
cardiac contractility and relaxation rates were enhanced. Furthermore,
both inotropic and lusitropic effects of
-adrenergic activation were
attenuated in the PLB knock-out (PLB-KO) mouse, including results from
isolated ventricular myocytes (8, 17, 22, 24, 27, 29, 37). These
results are clearly consistent with a major role of PLB in regulating
relaxation (as well as contractility). However, differences in
contraction amplitude and system nonlinearities (7) in previous studies
have prevented true quantitative comparison of the relative effects of
PLB and TnI phosphorylation on relaxation. In this study, we overcome this limitation to provide clear quantitative data concerning the
respective roles of TnI and PLB phosphorylation on the PKA-mediated lusitropic effect.
In the present study, we compare relaxation for contractions of matched
amplitude in the presence and absence of Iso in both ventricular
myocytes and muscles from both wild-type (WT) and PLB-KO mice (23).
This allows direct quantitative comparison of the lusitropic effect of
Iso on TnI alone (present in the PLB-KO) versus TnI plus PLB (present
in the WT). Our results indicate that phosphorylation of TnI has no
effect on the rate of myocyte or muscle relaxation during unloaded
contractions (relengthening). On the other hand, when isometric force
is developed, TnI phosphorylation produces a modest acceleration of
relaxation that is dependent on the load. Thus the lusitropic effect of
-adrenergic agonists mediated via TnI is extremely load dependent.
| |
METHODS |
|---|
|
|
|---|
Cardiac myocyte and muscle preparation. Isolation of ventricular myocytes from WT and PLB-KO mice was carried out as previously described (22). Briefly, hearts were excised from adult mice (species-matched WT and PLB-KO, 30-45 g) that were anesthetized with pentobarbital sodium (70 mg/kg ip). Hearts were mounted on a Langendorff perfusion apparatus and perfused with nominally Ca-free Tyrode solution for 6 min at 37°C. Perfusion was then switched to the same solution containing 0.8 mg/ml collagenase (type B, Boehringer Mannheim, Indianapolis, IN) and 0.03 mg/ml pronase (Boehringer Mannheim), with perfusion continuing until the heart became flaccid (~7-12 min). The ventricular tissue was then dispersed and filtered. The cell suspension was rinsed several times, and [Ca] was gradually increased to 1 mM. Before experimental use, the myocytes were plated onto Plexiglas superfusion chambers, with the glass bottoms of the chambers treated with laminin (GIBCO, Grand Island, NY) to increase cell adhesion.
Right ventricular papillary muscles were also dissected from WT and PLB-KO mice and mounted in a small volume (0.1 ml) tissue bath (5). One end was attached to a fixed post and the other to a hook connected to a stiff transducer (AE875, Aksjeselskapet Micro-Elektronikk, Horten, Norway) held by a micromanipulator. The muscle tapered from the ventricular wall toward the attachment to the valve such that the two-dimensional shape approached a triangle with a base width of ~0.6 mm and depth of 0.1-0.25 mm at the base and length of 2-3 mm. Force was normalized per cross-sectional area at the base using the approximation area = 0.75 × width × depth. Platinum wires in the chamber wall, parallel to the muscle length, were used to field stimulate the muscle at a normal frequency of 0.5 Hz.
Measurement of shortening and [Ca]i. Myocyte shortening was measured as previously described (2). Cells were under field stimulation (square waves) at 0.5 Hz, and experiments were conducted at room temperature (23°C). Cells were transilluminated by a red light source (to avoid interference with indo 1 epifluorescence measurement), and shortening was measured using a video-edge detection system (Crescent Electronics, Sandy, UT). This same system was used to monitor muscle shortening after the muscle was slackened to the point of zero developed force, by adjustment of the manipulator connected to the force transducer.
[Ca]i measurements were conducted simultaneously with contraction measurement in some cells. To obtain [Ca]i measurements while allowing myocytes to control their own intracellular environment (including [Na]) and action potential, cells were loaded with indo 1 by incubation with the acetoxymethyl ester (AM) form of the dye (indo 1-AM, 10 µM; Molecular Probes, Eugene, OR) for 20 min at room temperature. After loading was completed, the cells were superfused with normal Tyrode solution for at least 30 min to wash out excess indicator and allow deesterification (2). The excitation and emission system were as described (22). Briefly, excitation wavelength was 355 ± 5 nm, and the emission wavelength was selected as 405 ± 20 and 485 ± 20 nm. The average background fluorescence recorded at both wavelengths from cells not loaded with indo 1 was subtracted before the fluorescence ratio was calculated. Cell fluorescence signals were digitized at 120-133 Hz (filtered at 60 Hz) and stored on a computer. Details of the protocols are described in RESULTS.
Phosphorylation of isolated ventricular myocyte proteins. Isolated mouse ventricular myocytes were labeled with 32P, and protein phosphorylation was determined using a modified version of the protocol described by Wolska et al. (37). Myocytes from a single heart were suspended in 1 ml of the normal Tyrode solution containing 1 mM Ca and incubated with 0.15 mCi [32P]orthophosphate for 30 min at room temperature. Aliquots (100 µl) of the myocyte suspension were then mixed with 1.0 µM Iso. The reaction was stopped after 30, 60, 90, 120, or 180 s of treatment with Iso by adding SDS-stop solution containing 1 mM dithiothreitol, 30 mM Tris · HCl, 3 mM EDTA, 6% SDS, 15% glycerol, and a trace of bromophenol blue, pH 7.8. For a phosphorylation control, a myocyte aliquot was also incubated with 5 mM dibutyryl cAMP for 20 min, previously shown to produce maximal phosphorylation (21). All samples were boiled in microcentrifuge tubes for 5 min to dissociate the oligomeric state of PLB to its monomeric form before the samples were subjected to SDS-PAGE (using a 4-20% polyacrylamide gradient gel). Aliquots of samples containing 50 µg of myocyte protein, as determined by the Bio-Rad protein assay, were applied to each well. The SDS-PAGE gels were placed in the Storage Phosphor Screen Cassettes (Molecular Dynamics) for overnight exposure. Phosphorimage and densitometric data were obtained using a phosphorimager and the ImageQuant software from Molecular Dynamics. This method does not distinguish which amino acids are phosphorylated but provides simultaneous quantitative data for both PLB and TnI phosphorylation.
Solutions and statistical analaysis. Unless otherwise stated, reagents used were of analytic grade and supplied by Sigma (St. Louis, MO). The normal Tyrode (NT) solution contained (in mmol/l): 140 NaCl, 4 KCl, 1 MgCl2, 1 or 2 CaCl2, 10 glucose, and 5 HEPES, with the pH adjusted to 7.4 with NaOH at 23°C.
Values are given as means ± SE (n equals number of myocytes or muscles). Statistical comparisons were based on Student's t-test.
| |
RESULTS |
|---|
|
|
|---|
Maximal effect of Iso on twitch amplitude. Addition of Iso
increases contractions and Ca transients in both WT and PLB-KO myocytes. Figure 1A shows the
effect of steady-state exposure to 1 µM Iso on cell contraction
amplitude at 1 mM extracellular Ca concentration
([Ca]o). Cell shortening increased to 196 ± 30% of control after Iso was administered in PLB-KO myocytes
(n = 16, P < 0.01). In WT myocytes, contraction
amplitude increased to 369 ± 87% of control due to Iso
treatment (n = 7, P < 0.05). The percent
increase was significantly higher in WT myocytes compared with that
found in PLB-KO myocytes (P < 0.05). The results in muscles
were qualitatively similar, but Iso increased developed force to only
176 ± 10% in WT and 129 ± 4% in PLB-KO muscles (Fig. 1).
|
Matched contractions before and after Iso. Because contraction amplitudes have an intrinsic effect on the interpretation of relaxation kinetics (7), we compared the kinetics of cell relaxation only when contraction amplitudes were matched in the control and Iso. To accomplish this we used elevation of [Ca]o to raise control twitch contraction amplitude to levels comparable to those achieved by Iso application.
Figure 2 shows the usual experimental
protocol. Cells were initially perfused with NT containing 1 mM Ca
until twitch contractions reached steady state. The solution was then
switched to 2 mM Ca NT, and the cell contractions were allowed to reach
a new steady state. [Ca] was then reduced back to 1 mM and
the amplitude of contraction returned to the initial level. Finally, 1 µM Iso was added (in the same 1 mM Ca NT), and cell contraction
amplitude gradually increased over 1-2 min to a new steady state.
Contractions of matching amplitude without (Fig. 2, trace a)
and with Iso (trace b) were selected for direct comparison of
relaxation kinetics (see superimposed contractions in Fig
2).
|
In WT myocytes, addition of Iso or elevation of [Ca] to 2 mM had similar effects on contraction amplitude, but typically the steady-state twitch in 2 mM Ca NT was compared with a twitch with Iso, which occurred slightly before the eventual maximum steady state with Iso (as in the case in Fig. 2). Not surprisingly for PLB-KO myocytes, Iso did not increase twitch amplitude nearly as much as that observed in the WT myocytes (see also Fig. 1). Thus the PLB-KO cells were always in steady state with respect to Iso exposure for the contraction comparisons. Indeed, in >50% of the PLB-KO cells, addition of 1 µM Iso (in 1 mM Ca NT) did not increase contraction amplitude as much as raising [Ca]o from 1 to 2 mM. In these cases [Ca]o was also increased to 2 mM in the continued presence of 1 µM Iso. This allowed selection of a twitch in the sustained presence of Iso during the phase of increasing twitch amplitude toward a final steady state with 2 mM [Ca]o (for comparison with a control steady state twitch in 2 mM [Ca]o without Iso). Thus we can be particularly confident that the PLB-KO cells were being compared with maximal Iso stimulation.
Phosphorylation of TnI and PLB in intact myocytes. For this
protocol to be appropriate, it is important to know whether PLB and TnI
really get phosphorylated as expected during the exposure to Iso.
Figure 3A shows incorporation of
[32P]orthophosphate into cellular proteins in
intact isolated mouse ventricular myocytes that had been treated for
different times with 1 µM Iso to mimic our experimental
conditions. The last lane in Fig. 3A shows the effect of
exposure to 5 mM dibutyryl cAMP for 20 min as a control for maximal
phosphate incorporation. Figure 3B shows pooled results for TnI
and PLB phosphorylation normalized to the value for dibutyryl cAMP
(taken as 100%). There was some basal phosphorylation of PLB and TnI
before Iso exposure (17, 21, 37). However, exposure to 1 µM Iso
caused a marked and parallel increase in phosphorylation of both TnI
and PLB, reaching an apparent maximum within 2 min. This is similar to
previous results in intact WT and PLB-KO hearts (17), where there was also no difference in basal TnI phosphorylation between WT and PLB-KO
hearts. Moreover, the maximum level of phosphorylation achieved in 2 min of Iso in Fig. 3 was ~85% of that attained by 20 min of exposure
to 5 mM dibutyryl cAMP. These results indicate that Iso treatment
produced a marked increase in phosphorylation and that TnI and PLB get
phosphorylated to similar extents and with similar time courses.
|
Relaxation of twitches in isolated myocytes. Figure
4, A and B, shows
superimposed cell shortening traces in control and Iso from an
individual PLB-KO and WT myocyte, respectively. Time to peak and
overall duration of contraction were much shorter in PLB-KO than WT
myocytes. The time constant (
) for control cell relaxation during
steady-state twitch was also significantly faster in the PLB-KO mouse
(
= 65 ± 4 ms in WT vs. 28.7 ± 2 ms in PLB-KO; n = 5 and
8, respectively; P < 0.001). This is consistent with previous
reports (22, 37).
|
Contraction amplitudes in Fig. 4, A and B, were well
matched before and after Iso treatment in both PLB-KO and WT myocytes. In the PLB-KO myocyte, cell relaxation followed almost identical kinetics (
was 23 and 24 ms, before and after Iso, respectively). On
the other hand, the WT myocyte relaxed much faster after Iso treatment,
with
of 34 ms in Iso versus 72 ms in control. Figure 4C
shows pooled data from experiments like those in Figs. 2 and 4,
A and B. In PLB-KO myocytes there was no change in the
rate of cell relaxation (
= 28.7 ± 2.2 ms in control vs. 28.9 ± 3.3 ms in Iso, n = 8). In contrast in WT myocytes, the rate of
relaxation was much faster after Iso treatment (
= 65 ± 4 ms in
control vs. 46 ± 5 ms in Iso, n = 5; P < 0.01).
These kinetic comparisons were based on contractions of matched
amplitude, as shown in Fig 4D. These results suggest that for
matched contraction amplitudes, 1 µM Iso does not accelerate myocyte
relaxation in the absence of PLB.
With 1 µM Iso, the relaxation
in the WT (46 ± 5) was still
almost 60% longer than the relaxation in the PLB-KO with or without Iso treatment (29 ms). One possible explanation is that even with extremely strong
-adrenergic activation, PLB still partially inhibits Ca transport by the SR Ca-ATPase (16, 27). Other adaptive
changes in the PLB-KO cannot be ruled out.
Indo 1-loaded cells and Ca transients. In some cells,
intracellular Ca transients were also measured. However, the data in Figs. 2 and 4 were from cells that were not loaded with intracellular Ca indicators. This was done to avoid the potential effects of added
intracellular Ca buffer on relaxation kinetics. Indeed, in indo
1-loaded cells the control
of relaxation was longer than for
non-indo 1-loaded cells for both WT (115 ± 27 vs. 65 ± 4 ms) and
PLB-KO cells (46 ± 9 vs. 29 ± 2 ms). The higher variance for indo
1-loaded cells may also indicate cell-to-cell variability in the extent
of indo 1 loading. Twitch amplitude was also reduced in indo 1-loaded
cells (in PLB-KO from 15.6 ± 2.7 to 11.0 ± 2.7% of resting cell
length and in WT from 12.2 ± 3.3 to 7.8 ± 0.7% of resting cell length).
For cells in which Ca transients were measured together with
relaxation, the protocol was still the same, and twitches with Iso were
matched to control by contraction amplitude (101 ± 1% for WT and 101 ± 2% for PLB-KO). As in the non-indo 1-loaded cells (Fig.
4B),
of relaxation was unaltered by Iso in the PLB-KO myocytes (46 ± 9 vs. 45 ± 9) but was strongly accelerated in the WT
myocytes (115 ± 27 vs. 54 ± 13; P < 0.05).
Figure 5 shows Ca transients for
contractions where the amplitude of contraction was matched. The time
course of [Ca]i decline was similar before and
after Iso treatment in PLB-KO myocytes (Fig. 5A). In WT
myocytes, Iso again accelerated [Ca]i decline (Fig. 5B). Average results are shown in Fig. 5, C and
D. As for relaxation, [Ca]i decline was
greatly accelerated by Iso in the WT but not significantly altered in
the PLB-KO.
|
Figure 5D shows that the amplitudes of Ca transients were similar, where contraction amplitudes were matched (±Iso). Because PKA-dependent phosphorylation of TnI is known to decrease myofilament Ca sensitivity, it was expected that higher Ca transient peaks might be required for comparable contractions after Iso. Whereas there was a slight trend toward higher [Ca]i for matched contraction amplitude (especially in the WT), the difference did not reach statistical significance.
Relaxation of isometric force in multicellular preparations. The above-mentioned experiments were carried out in isolated myocytes that were shortening without appreciable external load. The influence of TnI phosphorylation on relaxation may be altered when the myocytes generate substantial force. Thus parallel experiments were performed to measure force development and relaxation in papillary muscles from WT and PLB-KO mice.
Figure 6 shows results from muscle force
measurements exactly analogous to those in Fig. 4 with myocyte
shortening. Again, Iso dramatically accelerated relaxation of force in
the WT by ~50% (from
= 80.5 ± 10.3 to 41.5 ± 8.4 ms). The
effect of Iso on the
of force relaxation in the PLB-KO was modest
(17.5%) but significant (from 38.5 ± 2.5 to 31.8 ± 2.0 ms). This
contrasts with results with unloaded myocyte shortening (Fig.
4C) and indicates that there may be a load dependence to the
lusitropic effect of TnI phosphorylation.
|
Figure 6, C and D, also includes control data in 1 mM
[Ca]o (i.e., when twitch amplitudes were not
matched with Iso twitches). It can be seen that relaxation is a bit
slower for the smaller amplitude control twitches for both PLB-KO and
WT, as expected for Ca transients (7). Even without our method to match
twitch amplitude for
comparisons, the effect of Iso on both WT and PLB-KO relaxation is apparent.
Load dependence of lusitropic effect of Iso. To explore this
issue further, muscle and sarcomere length were adjusted to vary developed force, from maximal to zero developed force (in which case
unloaded muscle shortening was measured). Figure
7A shows that in PLB-KO muscle,
relaxation during unloaded shortening was not altered by Iso, as seen
for myocyte shortening (Fig. 4C). However, with higher
developed force (Fig. 7B and C) there is a
progressive increase in the lusitropic effect of Iso in the PLB-KO.
This can be appreciated in Fig. 7D where the ratio of
with
Iso versus control (
Iso/
Ctl) is shown as
a function of developed force.
|
Figure 8 shows analogous results in WT
muscles. In the WT mouse the control relaxation is much slower than
that observed in the PLB-KO mouse. In addition, the acceleration of
relaxation induced by Iso is comparable at all levels of developed
force, including unloaded shortening. The load-independent effect of Iso in the WT mouse is emphasized by
Iso/
Ctl in Fig. 8D. This is
consistent with PLB phosphorylation being dominant in the WT, obscuring
a relatively small effect of TnI phosphorylation on relaxation.
|
In these experiments a different strategy was used to match twitch contraction amplitudes before and after Iso (altering muscle and sarcomere length vs. changing [Ca]o as in Figs. 2, 4-6). This has the advantage that Ca transients are not expected to change appreciably with sarcomere length. Thus similar results here serve as a control to rule out potential complicating effects of altered [Ca]o (such as activation of [Ca]i-dependent kinases and phosphatases). When force is varied by changing sarcomere length, there was also no apparent acceleration of relaxation as a function of load (Figs. 7D and 8D). This contrasts with the effects when amplitude was varied by changing [Ca]o or frequency (Fig. 6C, Refs. 7 and 22).
Figure 9A shows pooled data for
Iso/
Ctl in WT and PLB-KO muscles from
experiments like Figs. 7 and 8. The slope of the regression line is
significantly different from zero only in the PLB-KO case. The data in
Fig. 9A may create the false impression that Iso causes acceleration of relaxation in PLB-KO that reaches the same extent as in
WT. However, the control relaxation is very different in the PLB-KO
versus the WT such that the fast [Ca]i decline
in PLB-KO optimizes conditions for detection of an effect of TnI
phosphorylation on relaxation.
|
Figure 9B shows the approximate fraction of
acceleration,
which might be attributed to PLB phosphorylation versus TnI
phosphorylation. For this simplified analysis we used
data from
1) control WT and PLB-KO + Iso as the upper and lower limits
for
, 2) the
shift by Iso in PLB-KO as the TnI
component, and 3) the
shift in PLB-KO versus WT as the
maximum PLB component. We infer that without mechanical load, 100% of
the lusitropic effect of Iso in normal mouse heart is due to PLB
phosphorylation (for both myocyte and muscle). Similarly, under
near-maximal isometric load the TnI phosphorylation contributes 14%,
whereas PLB contributes 86%. These values were from the experiments
where [Ca]o was altered to match force before
and after Iso (Fig. 4). Similar values were obtained when alteration of
sarcomere length was used (Figs. 7 and 8).
| |
DISCUSSION |
|---|
|
|
|---|
We found that in the absence of PLB, cardiac relaxation at low
mechanical load is not accelerated by
-adrenergic receptor activation. However, with increasing developed force in PLB-KO, Iso-dependent TnI phosphorylation can accelerate relaxation. The key
novel aspects that allow quantitative analysis of this issue here are
the use of myocytes and muscles from PLB-KO mice and comparing twitches
of the same amplitude. Whereas Na/Ca exchange can contribute to
relaxation, the contribution in the mouse is very small and not
regulated by PKA (22).
PLB and TnI phosphorylation may both alter relaxation. It has
been known for some time that PLB phosphorylation accelerates Ca
transport by the cardiac SR Ca-ATPase and that this participates in
accelerated relaxation in response to
-adrenergic activation (18,
34). Indeed, the extremely rapid relaxation in the PLB-KO mouse at the
level of the intact animal, isolated heart, and myocyte emphasizes the
important natural inhibitory effect of PLB on the SR Ca-ATPase and
relaxation (8, 12, 17, 22, 23, 29, 37). Furthermore, there is much less
inotropic or lusitropic effect of Iso in the PLB-KO mouse compared with
the WT mouse (22, 23, 27, 37). Thus there are compelling
data indicating a major contribution of PLB phosphorylation to the
lusitropic effect of
-adrenergic agonists.
There are also compelling data to indicate that
-adrenergic agonists
lead to phosphorylation of TnI and that this decreases Ca affinity of
the myofilaments via an increase in dissociation rate of Ca from TnC
(28, 33, 38). Indeed, Zhang et al. (38) argued that PKA-dependent
phosphorylation of TnI also contributes to the lusitropic effect of
-adrenergic agonists, based on flash photolysis of the caged Ca
chelator diazo-2 in porcine skinned fibers (relaxation half-time
decreased from 110 to 70 ms). On the other hand, in similar experiments
in skinned guinea pig ventricular trabeculae, Johns et al. (14) found
no effect of PKA phosphorylation on the relaxation
(90 ms).
There have been few studies that have compared the influence of these two effects of PKA on relaxation in intact ventricular myocytes. McIvor et al. (26) used acetylcholine (which increased myofilament Ca sensitivity) to offset the effect of TnI phosphorylation by PKA but found that muscle relaxation was still accelerated. This clever strategy made a strong case for the dominance of PLB versus TnI phosphorylation in the lusitropic effect of Iso, but the use of acetylcholine limited the interpretation in quantitative terms. Talosi et al. (35) showed that withdrawal of Iso in the intact heart led to the recovery of the inotropic and lusitropic state comparable in time to the dephosphorylation of PLB rather than TnI (which occurred more slowly). A key limitation has always been that the TnI and PLB effects coexist in the cell, and if the TnI effect is somewhat less than the PLB effect, it may be more difficult to detect in the normal cellular environment (with a larger PLB effect).
Lusitropic effect of Iso in WT and PLB-KO myocytes. In the present study, we took advantage of the PLB-KO mouse to examine the impact of TnI phosphorylation in the complete absence of PLB. To extend previous work with the PLB-KO mouse above, we also took great care to compare twitches of the same amplitude before and after Iso treatment. This eliminated complications that may accrue from nonlinearities in the numerous processes involved when one uses normalization to compare twitches without Iso to the larger twitches produced by Iso exposure.
The mouse ventricular action potential lacks a plateau phase and is very short (like in the rat), such that it is essentially over before relaxation begins. This avoids potential complications due to the effects of action potential duration on relaxation. These concerns may be more relevant for larger mammals, which have a long action potential plateau phase and where [Ca]i decline is considerably slower than in the mouse. The mouse (like the rat) also has a relatively weak Na/Ca exchange system, which is the main Ca transport system that competes with the SR Ca-ATPase (3, 22). This system is therefore also unlikely to confound interpretation of our experiments.
The very rapid [Ca]i decline and relaxation in the PLB-KO mouse myocytes is perhaps the fastest natural cellular [Ca]i decline among cardiac species normally studied. This should really enhance the ability to detect a rate-limiting dissociation of Ca from TnC if it is physiologically relevant. It was thus initially surprising that even in the PLB-KO mouse, Iso and phosphorylation of TnI had no effect on myocyte relaxation (when contraction amplitude was matched). This suggests that even during these very rapid Ca transients (with [Ca]i decline much faster than normal), Ca transport rather than Ca dissociation from TnC is the rate-limiting step in the relaxation of isolated ventricular myocytes. The same observations were made in muscle preparations when they were not mechanically loaded. An important implication from this is that transport of Ca out of the cytosol is extremely critical in both the development of diastolic dysfunction and the strategies aimed at improving cardiac relaxation.
Because force can alter Ca dissociation from the myofilaments (1), it
was also important to examine this issue during relatively isometric
contractions. Whereas the effect of Iso on
of force relaxation is
much smaller in the PLB-KO than in WT muscle (Fig. 6), the
effect is highly significant. Our results do not determine which
proteins are responsible for the load dependence of relaxation effected
by PKA. Moreover, this lusitropic effect becomes negligible as the
developed force is reduced (Fig. 7). In contrast, the lusitropic effect
of Iso in WT muscle was independent of load and likely to
be almost completely due to PLB phosphorylation (Fig. 8). It is
possible that with the slower Ca transients in WT mice with PLB
present, Ca dissociation from the myofilaments is not rate limiting,
but [Ca]i decline is (even with Iso).
A simplified comparison of relaxation
values allows the first
quantitative estimates of the relative contributions of PLB and TnI
phosphorylation to the Iso-induced acceleration of relaxation in the WT
mouse (Fig. 9B). The values of 14-18% for TnI and
82-86% for PLB are certainly consistent with previous work, which
suggested that PLB was more important for this effect (22, 24, 26, 35,
37). It should be reemphasized that the [Ca]i
decline in PLB-KO mouse myocytes is much faster than in larger mammals and even in comparison to the WT mouse. Because a very fast
[Ca]i decline creates a situation where
dissociation of Ca from TnC is more likely to be rate limiting,
14-18% may be an upper limit for the contribution of TnI
phosphorylation to the kinetics of cardiac relaxation in the intact
myocyte. This would be especially true for myocytes in which the
of
relaxation is much slower than the 20-30 ms observed in the PLB-KO
mouse. Indeed, there was no significant force-dependent acceleration of
relaxation in the presence of Iso, even in the WT mouse (Fig. 8). This
may have been expected if TnI phosphorylation was a significant
contributor based on the characteristic effect of load in the PLB-KO
with Iso (Fig. 7). We conclude that TnI phosphorylation and
acceleration of Ca dissociation are probably extremely minor
contributors to the normal lusitropic effect of
-adrenergic
activation in heart. Rather, the rate of Ca transport and
[Ca]i decline are likely the main rate-limiting
steps during relaxation.
Inotropic effect of Iso in WT and PLB-KO myocytes. The two most important primary factors in mediating the positive inotropic effects of PKA activation are generally accepted to be phosphorylation of L-type Ca channels and PLB (6). Of course there could be other PKA targets that contribute to the inotropic state, such as ryanodine receptor (36) or C protein (11, but see also Ref. 10). TnI phosphorylation would by itself be negatively inotropic such that increases in Ca transient would have to more than offset this effect to allow increased contraction. For simplicity, we will focus on PLB and Ca current effects and assume that enhanced Ca current is the primary cause of the Iso-induced doubling of twitch amplitude in the PLB-KO.
Because Ca influx is only a very small fraction of activator Ca in rat and mouse myocytes (6, 22), the two- to threefold increase in Ca current typical with Iso (25) cannot be directly responsible for increased myofilament activation. A more likely explanation is the following. With more Ca entry per twitch, even an unaltered SR Ca pump (in PLB-KO) will result in higher SR Ca content and thus a greater pool of SR Ca will be available for release. Furthermore, the higher Ca current with Iso will provide a larger trigger of Ca-induced Ca release, resulting in increased fractional SR Ca release. In addition, even a modest increase in SR Ca load may increase the fraction of SR Ca released for a given Ca current trigger (4). There may also be increased Ca sensitivity of SR Ca release due to PKA-dependent phosphorylation of the ryanodine receptor (36). Thus there are multiple synergistic explanations for the increase of twitch amplitude even without PLB present. Clearly, these can overcome the negative effect of reduced myofilament Ca sensitivity induced by TnI phosphorylation. If we then add the stimulatory effect of PKA phosphorylation of PLB on the SR Ca-ATPase in the WT mouse, we would expect a much greater increase in SR Ca content available for release and consequently also greater fractional release. This could easily explain the twofold greater inotropic effect of Iso in the WT versus the PLB-KO mouse.
In conclusion, the effect of
-adrenergic activation on relaxation is
mediated entirely by PLB phosphorylation in the absence of external
mechanical load. However, during isometric contractions TnI
phosphorylation may contribute up to 14-18% of the acceleration of relaxation of developed force in response to Iso in WT mouse.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Steve Scaglione for careful work in isolating cardiac myocytes and Drs. Polly Hoffman and Matt Wolff for stimulating discussions.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-30077, HL-26057, HL-22318, and P40-RR-12358.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. M. Bers, Dept. of Physiology, Loyola Univ. Chicago, Stritch School of Medicine, 2160 South First Ave., Maywood, IL 60153 (E-mail: dbers{at}luc.edu).
Received 26 April 1999; accepted in final form 23 September 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Allen, D. G.,
and
S. Kurihara.
The effects of muscle length on intracellullar calcium transients in mammalian cardiac muscle.
J. Physiol. Lond.
327:
79-94,
1982
2.
Bassani, R. A.,
J. W. M. Bassani,
and
D. M. Bers.
Mitochondrial and sarcolemmal Ca2+ transport reduce [Ca2+]i during caffeine contractures in rabbit cardiac myocytes.
J. Physiol. Lond.
453:
591-608,
1992
3.
Bassani, J. W. M.,
R. A. Bassani,
and
D. M. Bers.
Relaxation of ferret ventricular myocytes: unusual interplay among calcium transport systems.
J. Physiol. Lond.
476:
295-308,
1994
4.
Bassani, J. W. M.,
W. Yuan,
and
D. M. Bers.
Fractional SR Ca release is altered by trigger Ca and SR Ca content in cardiac myocytes.
Am. J. Physiol. Cell Physiol.
268:
C1313-C1319,
1995
5.
Bers, D. M.
SR Ca loading in cardiac muscle preparations based on rapid cooling contractures.
Am. J. Physiol. Cell Physiol.
256:
C109-C120,
1989
6.
Bers, D. M.
Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, Netherlands: Kluwer Academic, 1991.
7.
Bers, D. M.,
and
J. R. Berlin.
Kinetics of [Ca]i decline in cardiac myocytes depend on peak [Ca]i.
Am. J. Physiol. Cell Physiol.
268:
C271-C277,
1995
8.
Chu, G.,
W. Luo,
J. P. Slack,
C. Tilgmann,
W. E. Sweet,
M. Spindler,
K. W. Saupe,
G. P. Boivin,
C. S. Moravec,
M. A. Matlib,
I. L. Grupp,
J. S. Ingwall,
and
E. G. Kranias.
Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Circ. Res.
78:
1064-1076,
1996
9.
Endoh, M.,
and
J. R. Blinks.
Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: Reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through
- and
-adrenoceptors.
Circ. Res.
62:
247-265,
1988
10.
Garvey, J. L.,
E. G. Kranias,
and
R. J. Solaro.
Phosphorylation of C-protein and phospholamban in isolated rabbit hearts.
Biochem. J.
249:
709-714,
1988[Web of Science][Medline].
11.
Hartzell, H. C.
Phosphorylation of C-protein in intact amphibian cardiac muscle. Correlation between 32P incorporation and twitch relaxation.
J. Gen. Physiol.
83:
563-588,
1984
12.
Hoit, B. D.,
S. F. Khoury,
S. F. E,
G. Kranias,
N. Ball,
and
R. Walsh.
In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency.
Circ. Res.
77:
632-637,
1995
13.
James, P.,
M. Inui,
M. Tada,
M. Chiesi,
and
E. Carafoli.
Nature and site of phospholamban regulation of the Ca pump of sarcoplasmic reticulum.
Nature
342:
90-92,
1989[Medline].
14.
Johns, E. C.,
S. J. Simnett,
I. P. Mulligan,
and
C. C. Ashley.
Troponin I phosphorylation does not increase the rate of relaxation following laser flash photolysis of diazo-2 in guinea-pig skinned trabeculae.
Pflügers Arch.
433:
842-844,
1997[Web of Science][Medline].
15.
Kim, H. W,
N. A. E. Steenaart,
D. G. Ferguson,
and
E. G. Kranias.
Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2+-ATPase with phospholamban in phospholipid vesicles.
J. Biol. Chem.
265:
1702-1709,
1990
16.
Kimura, Y.,
K. Kurzydlowski,
M. Tada,
and
D. H. MacLennan.
Phospholamban regulates the Ca2+-ATPase through intramembrane interactions.
J. Biol. Chem.
271:
21726-21731,
1996
17.
Kiss, E.,
I. Edes,
Y. Sato,
W. Luo,
S. B. Liggett,
and
E. G. Kranias.
-adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts.
Am. J. Physiol. Heart Circ. Physiol.
272:
H785-H790,
1997
18.
Koss, K. L.,
and
E. G. Kranias.
Phospholamban: a prominent regulator of myocardial contractility.
Circ. Res.
79:
1059-1063,
1996
19.
Kranias, E. G.,
and
R. J. Solaro.
Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart.
Nature
298:
182-184,
1982[Medline].
20.
Kranias, E. G.
Regulation of Ca2+ transport by cyclic 3':5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum.
Biochim. Biophys. Acta
844:
193-199,
1985[Medline].
21.
Lester, J. W.,
K. F. Gannaway,
R. A. Reardon,
L. D. Koon,
and
P. A. Hofmann.
Effects of adenosine and protein kinase C stimulation on mechanical properties of rat cardiac myocytes.
Am. J. Physiol. Heart Circ. Physiol.
271:
H1778-H1785,
1996
22.
Li, L.,
G. Chu,
E. G. Kranias,
and
D. M. Bers.
Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects.
Am. J. Physiol. Heart Circ. Physiol.
274:
H1335-H1347,
1998
23.
Luo, W.,
I. L. Grupp,
J. Harrer,
S. Ponniah,
G. Grupp,
J. J. Duffy,
T. Doetschman,
and
E. G. Kranias.
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of
-agonist stimulation.
Circ. Res.
75:
401-409,
1994
24.
Luo, W.,
B. W. Wolska,
I. L. Grupp,
J. M. Harrer,
K. Haghighi,
D. G. Ferguson,
J. P. Slack,
G. Grupp,
T. Doetschman,
R. J. Solaro,
and
E. G. Kranias.
Phospholamban gene dosage effects in the mammalian heart.
Circ. Res.
78:
839-847,
1996
25.
Masaki, H.,
Y. Sato,
W. Luo,
E. G. Kranias,
and
A. Yatani.
Characteristics of L-type Ca2+ channel and
-adrenergic stimulation in wild-type and phospholamban-deficient mouse cardiac myocytes (Abstract).
J. Mol. Cel. Cardiol.
28:
A160,
1996.
26.
McIvor, M. E.,
C. H. Orchard,
and
E. G. Lakatta.
Dissociation of changes in apparent myofibrillar Ca2+ sensitivity and twitch relaxation induced by adrenergic and cholinergic stimulation in isolated ferret cardiac muscle.
J. Gen. Physiol.
92:
509-529,
1988
27.
Pan, B. S.,
J. D. Hannon,
R. Wiedmann,
J. D. Potter,
E. G. Kranias,
Y. T. Shen,
R. G. Johnson, Jr.,
and
P. R. Housmans.
Effects of isoproterenol on twitch contraction of wild type and phospholamban-deficient murine ventricular myocardium.
J. Mol. Cell. Cardiol.
31:
159-66,
1993.
28.
Robertson, S. P.,
J. D. Johnson,
M. J. Holroyde,
E. G. Kraniaas,
J. D. Potter,
and
R. J. Solaro.
The effect of troponin I phosphorylation on the Ca2+ binding properties of the Ca2+ regulatory site of bovine cardiac troponin.
J. Biol. Chem.
257:
260-263,
1982
29.
Santana, L. F.,
E. G. Kranias,
and
W. J. Lederer.
Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes.
J. Physiol. Lond
503:
21-29,
1997
30.
Satsuya, S.,
M. Inui,
Y. Kimura,
T. Kuzuya,
and
M. Tada.
Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum.
J. Biol. Chem.
267:
1674-1679,
1992
31.
Sham, J. S. K.,
L. R. Jones,
and
M. Morad.
Phospholamban mediates the
-adrenergic-enhanced Ca uptake in mammalian ventricular myocytes.
Am. J. Physiol. Heart Circ. Physiol.
261:
H1344-H1349,
1991
32.
Simmerman, H. K. B.,
J. H. Collins,
J. L. Theibert,
A. D. Wegener,
and
L. R. Jones.
Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains.
J. Biol. Chem.
261:
13333-13341,
1986
33.
Solaro, R. J.,
A. J. Moir,
and
S. V. Perry.
Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.
Nature
262:
615-617,
1976[Medline].
34.
Tada, M.,
M. Inui,
M. Yamada,
M. A. Kadoma,
T. Kuzuya,
H. Abe,
and
S. Kakiuchi.
Effect of phospholamban phosphorylation catalyzed by adenosine 3',5'-monophosphate and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum.
J. Mol. Cell. Cardiol.
15:
335-346,
1983[Web of Science][Medline].
35.
Talosi, L.,
I. Edes,
and
E. G. Kranias.
Intracellular mechanisms mediating reversal of
-adrenergic stimulation in intact beating hearts.
Am. J. Physiol. Heart Circ. Physiol.
264:
H791-H797,
1993
36.
Valdivia, H. H.,
J. H. Kaplan,
G. C. R. Ellis-Davies,
and
W. J. Lederer.
Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.
Science
267:
1997-1999,
1995
37.
Wolska, B. M.,
M. O. Stojanovic,
W. Luo,
E. G. Kranias,
and
R. J. Solaro.
Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+.
Am. J. Physiol. Cell Physiol.
271:
C391-C397,
1996
38.
Zhang, R.,
J. Zhao,
A. Mandveno,
and
J. D. Potter.
Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation.
Circ. Res.
76:
1028-1035,
1995
This article has been cited by other articles:
![]() |
J. M. O'Donnell, A. Fields, X. Xu, S. A. K. Chowdhury, D. L. Geenen, and J. Bi Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2483 - H2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Manni, J. H. Mauban, C. W. Ward, and M. Bond Phosphorylation of the cAMP-dependent Protein Kinase (PKA) Regulatory Subunit Modulates PKA-AKAP Interaction, Substrate Phosphorylation, and Calcium Signaling in Cardiac Cells J. Biol. Chem., August 29, 2008; 283(35): 24145 - 24154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Ryall, J. D. Schertzer, K. T. Murphy, A. M. Allen, and G. S. Lynch Chronic {beta}2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2587 - H2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. MacDonnell, G. Garcia-Rivas, J. A. Scherman, H. Kubo, X. Chen, H. Valdivia, and S. R. Houser Adrenergic Regulation of Cardiac Contractility Does Not Involve Phosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Circ. Res., April 25, 2008; 102(8): e65 - e72. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. K. Birkeland, F. Swift, N. Tovsrud, U. Enger, P. K. Lunde, E. Qvigstad, F. O. Levy, O. M. Sejersted, and I. Sjaastad Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2367 - H2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Ramirez-Correa and A. M. Murphy Is Phospholamban or Troponin I the "Prima Donna" in -Adrenergic Induced Lusitropy? Circ. Res., August 17, 2007; 101(4): 326 - 327. [Full Text] [PDF] |
||||
![]() |
S.-i. Yasuda, P. Coutu, S. Sadayappan, J. Robbins, and J. M. Metzger Cardiac Transgenic and Gene Transfer Strategies Converge to Support an Important Role for Troponin I in Regulating Relaxation in Cardiac Myocytes Circ. Res., August 17, 2007; 101(4): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guellich, T. Damy, Y. Lecarpentier, M. Conti, V. Claes, J.-L. Samuel, J. Quillard, J.-L. Hebert, T. Pineau, and C. Coirault Role of oxidative stress in cardiac dysfunction of PPAR{alpha}-/- mice Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H93 - H102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. E. Hewett, R. Klevitsky, J. Robbins, V. Sarin, D. C. Zawieja, G. A. Meininger, and M. Muthuchamy Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H552 - H563. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Mills, H. Kubo, D. M. Harris, R. M. Berretta, V. Piacentino III, and S. R. Houser Phosphorylation of phospholamban at threonine-17 reduces cardiac adrenergic contractile responsiveness in chronic pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H61 - H70. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sarin, R. D Gaffin, G. A Meininger, and M. Muthuchamy Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via {alpha}5{beta}1 integrin J. Physiol., April 15, 2005; 564(2): 603 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fukuda, Y. Wu, P. Nair, and H. L. Granzier Phosphorylation of Titin Modulates Passive Stiffness of Cardiac Muscle in a Titin Isoform-dependent Manner J. Gen. Physiol., February 28, 2005; 125(3): 257 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Gaffin, C. W Tong, D. C Zawieja, T. E Hewett, R. Klevitsky, J. Robbins, and M. Muthuchamy Charged residue alterations in the inner-core domain and carboxy-terminus of {alpha}-tropomyosin differentially affect mouse cardiac muscle contractility J. Physiol., December 15, 2004; 561(3): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland, D. J. Grieve, A. C. Cave, E. Sparks, R J. Solaro, and A. M. Shah Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically J. Physiol., May 1, 2004; 556(3): 835 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Llach, J. Huang, F. Sederat, L. Tort, G. Tibbits, and L. Hove-Madsen Effect of {beta}-adrenergic stimulation on the relationship between membrane potential, intracellular [Ca2+] and sarcoplasmic reticulum Ca2+ uptake in rainbow trout atrial myocytes J. Exp. Biol., March 15, 2004; 207(8): 1369 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takimoto, D. G. Soergel, P. M.L. Janssen, L. B. Stull, D. A. Kass, and A. M. Murphy Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites Circ. Res., March 5, 2004; 94(4): 496 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Pena and B. M Wolska Troponin I phosphorylation plays an important role in the relaxant effect of {beta}-adrenergic stimulation in mouse hearts Cardiovasc Res, March 1, 2004; 61(4): 756 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Metzger and M. V. Westfall Covalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation Circ. Res., February 6, 2004; 94(2): 146 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chu, G. F. Egnaczyk, W. Zhao, S.-H. Jo, G.-C. Fan, J. E. Maggio, R.-P. Xiao, and E. G. Kranias Phosphoproteome Analysis of Cardiomyocytes Subjected to {beta}-Adrenergic Stimulation: Identification and Characterization of a Cardiac Heat Shock Protein p20 Circ. Res., February 6, 2004; 94(2): 184 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Katra, E. Pruvot, and K. R. Laurita Intracellular calcium handling heterogeneities in intact guinea pig hearts Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H648 - H656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Brittsan, K. S. Ginsburg, G. Chu, A. Yatani, B. M. Wolska, A. G. Schmidt, M. Asahi, D. H. MacLennan, D. M. Bers, and E. G. Kranias Chronic SR Ca2+-ATPase Inhibition Causes Adaptive Changes in Cellular Ca2+ Transport Circ. Res., April 18, 2003; 92(7): 769 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chaudhri, F. del Monte, R. J. Hajjar, and S. E. Harding Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2450 - H2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland and J. C Kentish Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae J. Physiol., October 1, 2002; 544(1): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huke, V. Prasad, M. L. Nieman, K. J. Nattamai, I. L. Grupp, J. N. Lorenz, and M. Periasamy Altered dose response to beta -agonists in SERCA1a-expressing hearts ex vivo and in vivo Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H958 - H965. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Michele, P. Coutu, and J. M. Metzger Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins Physiol Genomics, May 10, 2002; 9(2): 103 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Satoh, T. Sato, M. Shimada, K. Yamada, and Y. Kitada Lusitropic Effect of MCC-135 Is Associated with Improvement of Sarcoplasmic Reticulum Function in Ventricular Muscles of Rats with Diabetic Cardiomyopathy J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fink, D. R. Zakhary, J. A. Mackey, R. W. Desnoyer, C. Apperson-Hansen, D. S. Damron, and M. Bond AKAP-Mediated Targeting of Protein Kinase A Regulates Contractility in Cardiac Myocytes Circ. Res., February 16, 2001; 88(3): 291 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M.N. Terracciano, K. D. Philipson, and K. T. MacLeod Overexpression of the Na+/Ca2+ exchanger and inhibition of the sarcoplasmic reticulum Ca2+-ATPase in ventricular myocytes from transgenic mice Cardiovasc Res, January 1, 2001; 49(1): 38 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Eisner, H. S. Choi, M. E. Diaz, S. C. O'Neill, and A. W. Trafford Integrative Analysis of Calcium Cycling in Cardiac Muscle Circ. Res., December 8, 2000; 87(12): 1087 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-S. Song, S.-Q. Wang, R.-P. Xiao, H. Spurgeon, E. G. Lakatta, and H. Cheng {beta}-Adrenergic Stimulation Synchronizes Intracellular Ca2+ Release During Excitation-Contraction Coupling in Cardiac Myocytes Circ. Res., April 27, 2001; 88(8): 794 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kentish, D. T. McCloskey, J. Layland, S. Palmer, J. M. Leiden, A. F. Martin, and R. J. Solaro Phosphorylation of Troponin I by Protein Kinase A Accelerates Relaxation and Crossbridge Cycle Kinetics in Mouse Ventricular Muscle Circ. Res., May 25, 2001; 88(10): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |